Literature DB >> 7439635

Focal hemorrhagic necrosis of the liver. A clinicopathological entity possibly related to oral contraceptives.

E S Zafrani, Y Pinaudeau, B Le Cudonnec, M Julien, D Dhumeaux.   

Abstract

A 44-year-old woman who had been taking oral contraceptives for 10 yr developed abdominal pain and abnormalities of liver tests, which led to the discovery of multiple filling defects on liver scan and of large hepatic zones of decreased density on computerized tomography of the abdomen. These abnormalities were due to sharply demarcated areas of hepatic multilobular hemorrhagic necrosis, associated with marked changes of liver arterioles and small hepatic veins. Since oral contraceptives have been incriminated in the genesis of hepatic vascular alterations, the possible relationship between focal hemorrhagic necrosis of the liver and these agents is suggested.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439635

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Computed tomography abnormalities in hepatic infarction.

Authors:  E S Zafrani; Y Pinaudeau; B Le Cudonnec; D Larde; D Dhumeaux
Journal:  Dig Dis Sci       Date:  1983-03       Impact factor: 3.199

Review 2.  Hepatobiliary complications of oral contraceptives.

Authors:  M C Lindberg
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

3.  Focal hemorrhagic necrosis of the liver. A rare cause of hemoperitoneum.

Authors:  H Takiff; J J Brems; P J Pockros; M L Elliott
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

Review 4.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

5.  Peliosis hepatis mimicking cancer: A case report.

Authors:  Weidong Dai; Dewu Zhong
Journal:  Oncol Lett       Date:  2013-07-19       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.